Navigation Links
AMDL Inc. Announces Second Quarter 2008 Results; Company Posts $5.8 Million in Sales With a Revenue Increase of 140%
Date:8/15/2008

revenues in the third and fourth quarters of 2008.

According the Gary Dreher, President and Chief Operating Office of AMDL, "We remain highly optimistic about AMDL's near-term outlook, and confident we will meet our 2008 business and financial targets. This means, at a minimum, we are focused on doubling sales in 2008 and annually over the next three years, leveraging our recent FDA clearance to market for our DR-70(R) cancer monitoring product, and securing additional regulatory approvals for other key products including the MyHPV(R) Chip Kit Test."

For FY2008 AMDL has targeted net sales ranging between $30 to $38.7 million with gross margins of 46% to 52% -- a 100% increase over the same period in 2007 where the Company achieved gross revenues of $15 million with a gross margin of 54% of gross revenues. For FY2008, R&D and SG&A expenses are expected to range between $6.8 to $9.5 million, including stock-based (common shares, warrants and options) compensation expenses. This is compared to $9.9 million over the same period in 2007. Net income after taxes is expected to be between $9.5 and $12.2 million including any foreign currency adjustments.

Currently, AMDL is in process of securing debt financing based on its AAA bank rating for its real estate and plant assets in China. The Company plans to secure $4 million in debt financing, which will be primarily used to fund on-going product distribution and sales throughout China; the development of additional production lines in China; execution on its business development strategy for the recently FDA-approved DR-70(R) monitoring test for colorectal cancer; securing SFDA-approval for DR-70(R) and MyHPV(R) Chip Test Kit: and the marketing, sales and distribution for the newest Goodank(R) anti-aging product formulations. The company also plans to use a portion of the funds to acquire a China-based distributor which will in effect allow AMDL to become an independent distributor in specific regions i
'/>"/>

SOURCE AMDL
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
2. Arno Therapeutics Announces Appointment of Brian Lenz, CPA as Chief Financial Officer
3. Fufeng Announces 2008 Interim Results With Strong Sign of Recovery
4. Advanced Life Sciences Announces Second Quarter 2008 Financial Results
5. Ondine Biopharma Announces Second Quarter 2008 Financial Results
6. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
7. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
8. BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis
9. Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document
10. POET Announces That Cellulosic Ethanol Pilot Facility Will Be Operational This Year
11. China Medicine Announces Strong Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Station, Texas (PRWEB) September 18, 2014 ... System Chancellor John Sharp, Texas A&M Health Science ... the U.S. Department of Health and Human Services ... today dedicated a national pandemic influenza vaccine manufacturing ... serve as an anchor for the Texas A&M ...
(Date:9/18/2014)... , Sept. 18, 2014 Research and ... "Global and Chinese Stem Cell Industry Report, 2014-2017" ... are undifferentiated biological cells that can differentiate into specialized ... stem cells. Stem cell therapy can be applied to ... system disease), nervous system diseases, damage or lesion of ...
(Date:9/18/2014)... 2014 Research and Markets has ... Industry Report 2014" report to their offering. ... is a professional and in-depth study on the current ... The report provides a basic overview of the industry ... human albumin market analysis is provided for the international ...
(Date:9/18/2014)... Leatherwood Plastics has selected Vycom’s Flametec ... competitive in the semiconductor, clean room and medical ... product quality and productivity, according to Dwight Leatherwood, ... 1980 in Lewisville, TX, Leatherwood Plastics ... the business. Much of Leatherwood’s equipment building relies ...
Breaking Biology Technology:Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 2Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 3Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 4Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3Global Human Albumin Industry Report 2014 2Global Human Albumin Industry Report 2014 3Leatherwood Plastics Selects Vycom’s Flametec PVC-C Material to Stay Competitive in Semiconductor and Lab Equipment Industries 2
... pirfenidone role in treatment of patients with IPF -- Ground-breaking ... Strong data from 14-day triple combination study of ITMN-191 in ... (Nasdaq: ITMN ) today announced results from operations ... InterMune reported a net loss for the first quarter ...
... ERES ), a leading provider of centralized ECG, ... device, and related industries, announced today results for the first ... refer to changes from the same period a year ago.Highlights ... , Quarterly ...
... 30 Resonant Medical, an innovator in 3D ... appointment of Stephen Whisenhunt to the position of ... will lead the Company,s growing global sales team ... than 18 years of radiation oncology industry experience ...
Cached Biology Technology:InterMune Reports First Quarter 2009 Financial Results and Business Highlights 2InterMune Reports First Quarter 2009 Financial Results and Business Highlights 3InterMune Reports First Quarter 2009 Financial Results and Business Highlights 4InterMune Reports First Quarter 2009 Financial Results and Business Highlights 5InterMune Reports First Quarter 2009 Financial Results and Business Highlights 6InterMune Reports First Quarter 2009 Financial Results and Business Highlights 7InterMune Reports First Quarter 2009 Financial Results and Business Highlights 8InterMune Reports First Quarter 2009 Financial Results and Business Highlights 9InterMune Reports First Quarter 2009 Financial Results and Business Highlights 10InterMune Reports First Quarter 2009 Financial Results and Business Highlights 11InterMune Reports First Quarter 2009 Financial Results and Business Highlights 12InterMune Reports First Quarter 2009 Financial Results and Business Highlights 13ERT Reports First Quarter 2009 Results 2ERT Reports First Quarter 2009 Results 3ERT Reports First Quarter 2009 Results 4ERT Reports First Quarter 2009 Results 5ERT Reports First Quarter 2009 Results 6ERT Reports First Quarter 2009 Results 7ERT Reports First Quarter 2009 Results 8ERT Reports First Quarter 2009 Results 9Resonant Medical Expands Sales Organization with Appointment of Vice President of Global Sales and Marketing 2
(Date:9/19/2014)... a species which over thousands of years has adapted to ... substance that makes the cold dangerous for you. , This ... , and the cold provoking substance, called nonylphenol, comes from ... is suspected of being a endocrine disruptor, but when entering ... worm,s ability to protect the cells in its body from ...
(Date:9/19/2014)... legume plants regulate their symbiotic relationship with soil ... through the plant structure from leaves into the ... in the roots. This collaborative study was conducted ... Biology, the Graduate University for Advanced Studies (SOKENDAI), ... in Japan. , Legumes, an important plant ...
(Date:9/18/2014)... Bulletin study uses tree rings to document arroyo ... in northern New Mexico, USA. By determining burial dates ... were able to precisely date arroyo sedimentary beds 30 ... with aerial imagery, LiDAR, longitudinal profiles, and repeat surveys ... are deep, oversized channels that have vertical or steeply ...
Breaking Biology News(10 mins):Environmental pollutants make worms susceptible to cold 2Environmental pollutants make worms susceptible to cold 3For legume plants, a new route from shoot to root 2Tree rings and arroyos 2Tree rings and arroyos 3Tree rings and arroyos 4Tree rings and arroyos 5Tree rings and arroyos 6Tree rings and arroyos 7
... and Duke University have developed nanoscale "patches" that can ... more responsive to signals that control cell activity. The ... engineering research. The research takes advantage of the ... via physical contact. Specifically, when targeted receptors on the ...
... mainland - are taking the lead in making plans to ... Diana Reckien, of Columbia University in the US, in a ... analysed the relevant strategic policies and planning documents of 200 ... in every three European cities has no plans on the ...
... "smart": too elementary to be able to reproduce by themselves, ... of their own DNA so that it is transcribed by ... inject their own genetic material into the cells they infect. ... (the International School for Advanced Studies in Trieste), has studied ...
Cached Biology News:Researchers use nanoscale 'patches' to sensitize targeted cell receptors 2The reality behind Europe's response to climate change 2Tidy knots are faster 2
Mouse monoclonal [1Q17] to TGE Virus peplomer ( Abpromise for all tested applications)....
B3GALT2 Immunogen: B3GALT2 (NP_003774, 324 a.a. ~ 423 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rabbit polyclonal to Lck (phospho Y192) ( Abpromise for all tested applications). entrezGeneID: 3932 SwissProtID: P06239...
...
Biology Products: